EQT-backed Galderma sells Bübchen
Galderma (formerly known as Nestle Skin Health), a portfolio company of EQT, has sold its baby skincare subsidiary Bübchen to Dallmann's Pharma, a wholly owned subsidiary of Germany-based confectionery group Katjes.
More on Exits
Goldman Sachs, Kennet sell Nuxeo to Hyland Software
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
Pride Capital sells stake in Kairos to trade
Direct lender invested in Kairos in 2018 and was part of Main Capital until its spin-out in 2019
Beyond Capital Partners sells Sysob to trade
GP invested in the IT equipment distributor in 2016 via BCP Fund I; it is on the road for Fund II
Summa-backed Olink files for US IPO
Olink has been backed by Summa Equity since March 2019 and increased its revenues by 16.7% in 2020
Latest News
AM Ventures holds first close for 3D printing venture fund
Additive manufacturing-focused firm has a target of €100m for the vehicle
LDC buys Sohonet from FPE Capital
With LDC's support, the company intends to boost its international growth and explore complementary acquisitions
Goldman Sachs, Kennet sell Nuxeo to Hyland Software
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
BGF-backed TIG bolts on ThirdSpace
Acquisition of the cybersecurity and identity firm is backed by BGF and Santander Growth Capital